News NHS and Drayson to pilot intensive care digital sensors Chelsea and Westminster Hospital to adopt Drayson wireless environment sensors.
News NHS and Drayson Technologies unveil groundbreaking digital h... NHS and Drayson Technologies unveil groundbreaking digital health deal
News Akebia joins GSK in US market for oral CKD anaemia drugs The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS
Digital Sponsored Innovation as Strategy: Enabling life sciences of the future Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.